Plasma parathyroid hormone is associated with vascular dementia and cerebral hyperintensities in two community-based cohorts

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 11, 2014, Pages 4181-4189

  Hagström, Emil ^a   Kilander, Lena ^b   Nylander, Ruta ^c   Larsson, Elna Marie ^c   Michaëlsson, Karl ^d   Melhus, Hakan ^a   Ahlström, Hakan ^c   Johansson, Lars ^c   Lind, Lars ^a   Ärnlöv, Johan ^a,e  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c Section of Radiology   (Sweden)

^d Institution of Surgical Sciences   (Sweden)

^e DALARNA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD VESSEL; COMMUNITY SAMPLE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; MULTIINFARCT DEMENTIA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARATHYROID HORMONE BLOOD LEVEL; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOLOGICAL PARAMETERS; RISK ASSESSMENT; RISK FACTOR; WHITE MATTER HYPERINTENSITY; BLOOD; BRAIN; CEREBRAL SMALL VESSEL DISEASES; DEMENTIA, VASCULAR; FEMALE; LONGITUDINAL STUDY; MIDDLE AGED; PATHOLOGY; VERY ELDERLY; WHITE MATTER;

AGED; AGED, 80 AND OVER; BRAIN; CEREBRAL SMALL VESSEL DISEASES; DEMENTIA, VASCULAR; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARATHYROID HORMONE; RISK FACTORS; WHITE MATTER;

EID: 84910020570     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1736     Document Type: Article

References (34)

1. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004; 15: 2208-2218.
2. Garcia de la Torre N, Wass JA, Turner HE. Parathyroid adenomas and cardiovascular risk. Endocr Relat Cancer. 2003; 10: 309-322.
3. Hagström E, Hellman P, Larsson TE, et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation. 2009; 119: 2765-2771.
4. Hagström E, Ingelsson E, Sundström J, et al. Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur J Heart Fail. 2010; 12: 1186-1192.
5. Feng L, Yap KB, Yeoh LY, Ng TP. Kidney function and cognitive and functional decline in elderly adults: Findings from the Singapore longitudinal aging study. J Am Geriatr Soc. 2012; 60: 1208-1214.
6. Vestergaard P, Mollerup CL, Frøkjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L. Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg. 2003; 27: 216-222.
7. Walker MD, Fleischer J, Rundek T, et al. Carotid vascular abnormalities in primary hyperparathyroidism. J Clin Endocrinol Metab. 2009; 94: 3849-3856.
8. Perkovic V, Hewitson TD, Kelynack KJ, Martic M, Tait MG, Becker GJ. Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells. Kidney Blood Press Res. 2003; 26: 27-33.
9. Sahathevan R, Brodtmann A, Donnan GA. Dementia, stroke, and vascular risk factors; a review. Int J Stroke. 2012; 7: 61-73.
10. Staessen JA, Richart T, Birkenhäger WH. Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. Hypertension. 2007; 49: 389-400.
11. Walker MD, McMahon DJ, Inabnet WB, et al. Neuropsychological features in primary hyperparathyroidism: A prospective study. J Clin Endocrinol Metab. 2009; 94: 1951-1958.
12. Vogels SC, Emmelot-Vonk MH, Verhaar HJ, Koek HL. The association of chronic kidney disease with brain lesions on MRI or CT: A systematic review. Maturitas. 2012; 71: 331-336.
13. Annweiler C, Llewellyn DJ, Beauchet O. Low serum vitaminDconcentrations in Alzheimer's disease: A systematic review and metaanalysis. J Alzheimers Dis. 2013; 33: 659-674.
14. Byberg L, Siegbahn A, Berglund L, McKeigue P, Reneland R, Lithell H. Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-yearold men. Arterioscler Thromb Vasc Biol. 1998; 18: 258-264.
15. Lind L, Fors N, Hall J, Marttala K, Stenborg A. A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Arterioscler Thromb Vasc Biol. 2005; 25: 2368-2375.
16. Levey AS, Stevens LA, Schmid CH, et al. Anew equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150: 604-612.
17. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology. 1992; 42: 473-480.
18. Rönnemaa E, Zethelius B, Lannfelt L, Kilander L. Vascular risk factors and dementia: 40-year follow-up of a population-based cohort. Dement Geriatr Cogn Disord. 2011; 31: 460-466.
19. Rashid G, Bernheim J, Green J, Benchetrit S. Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. Am J Physiol Renal Physiol. 2007; 292: F1215-F1218.
20. Smith JC, Page MD, John R, et al. Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab. 2000; 85: 3515-3519.
21. Braverman ER, Chen TJ, Chen AL, et al. Age-related increases in parathyroid hormone may be antecedent to both osteoporosis and dementia. BMC Endocr Disord. 2009; 9: 21.
22. Kosch M, Hausberg M, Vormbrock K, et al. Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc Res. 2000; 47: 813-818.
23. Dotzenrath CM, Kaetsch AK, Pfingsten H, et al. Neuropsychiatric and cognitive changes after surgery for primary hyperparathyroidism. World J Surg. 2006; 30: 680-685.
24. Björkman MP, Sorva AJ, Tilvis RS. Does elevated parathyroid hormone concentration predict cognitive decline in older people? Aging Clin Exp Res. 2010; 22: 164-169.
25. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003; 348: 1215-1222.
26. Inzitari D, Pracucci G, Poggesi A, et al. Changes in white matter as determinant of global functional decline in older independent outpatients: Three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ. 2009; 339: b2477.
27. Shore D, Wills MR, Savory J, Wyatt RJ. Serum parathyroid hormone concentrations in senile dementia (Alzheimer's disease). Int J Gerontol. 1980; 35: 656-662.
28. Thal DR, Grinberg LT, Attems J. Vascular dementia: Different forms of vessel disorders contribute to the development of dementia in the elderly brain. Exp Gerontol. 2012; 47: 816-824.
29. Griva K, Thompson D, Jayasena D, Davenport A, Harrison M, Newman SP. Cognitive functioning pre-to post-kidney transplantation-a prospective study. Nephrol Dial Transplant. 2006; 21: 3275-3282.
30. Harciarek M, Biedunkiewicz B, Lichodziejewska-Niemierko M, Debska-Slizień A, Rutkowski B. Cognitive performance before and after kidney transplantation: A prospective controlled study of adequately dialyzed patients with end-stage renal disease. J Int Neuropsychol Soc. 2009; 15: 684-694.
31. Peterson A, Mattek N, Clemons A, Bowman GL, Buracchio T, Kaye J, Quinn J. Serum vitamin D concentrations are associated with falling and cognitive function in older adults. J Nutr Health Aging. 2012; 16: 898-901.
32. Jorde R, Sundsfjord J, Bønaa KH. Determinants of serum calcium in men and women. The Tromsø Study. Eur J Epidemiol. 2001; 17: 1117-1123.
33. Larsson TE, Olauson H, Hagström E, et al. Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community. Arterioscler Thromb Vasc Biol. 2010; 30: 333-339.
34. Misiak B, Cialkowska-Kuzminska M, Frydecka D, Chladzinska-Kiejna S, Kiejna A. European studies on the prevalence of dementia in the elderly: time for a step towards a methodological consensus. Int J Geriatr Psychiatry. 2013; 28: 1211-1221.